Leukemia, Myelodysplasia, Transplantation
Video
Mismatched Cord Blood
Video
Triple Therapy for CLL
News
Study shows imatinib response is durable and improves with time
SAN FRANCISCO—The longest duration study of imatinib treatment for patients with Ph+ CML shows 86% of patients are still alive 7 years after...